Report Store Get Proposal

Home Blog Notizia 37

Notizia - Recent Pharma, Healthcare and Biotech Happenings

uncomplicated-urinary-tract-infections-market

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market

Uncomplicated Urinary Tract Infections are one of the most commonly diagnosed infections in the US, with the maximum prevalence in women who are sexually active. A wide range of pathogens can be a reason behind the manifestation of the condition; however, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis, and Staphylococcus saprophyticus are some of the most common causes. A study estimates that approximately one-half of all women will contract UTI in their lifetimes, with one-fourth of total UTI prevalence contracting recurrent infections. DelveInsight’s Uncomplicated Urinary Tract Infections epidemiological analysis demonstrated that ...

Explore More...

depression

Sage’s drug meets phase 3; Blocking 2 key pathways help in tackling TNBC; FDA clears Paragonix; FDA gives a nod

Juvenescence

Atlas Venture raises; Harpoon files IPO; Boston Scientific bags Millipede

vedanta

Vedanta raises; Relay Therapeutics reels in; Gene therapy for SMA

Gilead

Tetra, Shionogi sign deal; Amgen remunerates; Gilead’s fibrotic disease deal

HER2 Drug Meets Phase 1b; Neurons ward off Alzheimer’s; Bristol-Myers, H3 Biomedicine discover RNA splicing

alzheimer's

Lilly remunerates AC Immune; Akero adds $70M; Ra Pharma $100M

patent ductus arteriosus

Notizia

alzheimer's

Roche signs Icagen; UCB devote $255M; Siemens Healthineers celebrates

Johnson & Johnson

Notizia

vedanta

Prometic bags $50M; Vedanta receives $12M; Humira biosimilar deal

Cambrex acquires Avista; Sobi pays $50M; LEO Pharma signs deal; Boston Scientific remunerates

patent ductus arteriosus

Notizia

Synthorx needs IPO; Deerfield puts up $80M; SVB remunerates; Celgene’s deal

glaxosmithkline

Notizia

TNBC Triple Negative Breast Cancer

Triple Negative Breast Cancer

Sanofi

Gordon and Betty Moore Foundation gives $85M; Omeicos raises; Sanofi signs deal; Lilly grabs

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly